OPTIMIZERx Corporation

February 03, 2012 08:00 ET

OPTIMIZERx Announces Company Updates

ROCHESTER, MI--(Marketwire - Feb 3, 2012) - OPTIMIZERx Corp (OTCBB: OPRX) announces key updates:

OPTIMIZERx Corporation expects fourth quarterly 2011 results to show its first profitable quarter.

The company completed its move to their new headquarters in Rochester Michigan to support its growth.

Expansion of SampleMD's Rx eCoupon technology in other ePrescribing platforms is on track to double existing reach of providers by end of first quarter.

Beta launch of a new, more efficient way for doctors' offices to set up available time slots and frequency rules to allow pharmaceutical reps to schedule appointments -- without interrupting their staff. In turn, participating pharmaceutical representatives will be able to access the SampleMD physician scheduling portal to better utilize their time educating doctors and staff versus sitting in the waiting rooms. "The SampleMD eSchedule solution is the latest example of how our company is responding to new market opportunities to improve the physician's interface with pharmaceutical manufacturers to access the vast array of resources on their terms," stated Terry Hamilton, Senior Vice President. OptimizeRx is initially partnering with Novartis Pharmaceuticals to roll this out in two large health systems.

About OPTIMIZERx Corp.

OPTIMIZERx Corp. provides unique consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. For more information, please go to


This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended and such section 21E of the Securities Act of 1934, amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Contact Information